Table 2.
Summary of double blind, placebo controlled, randomised controlled trials of oral steroids for preschool wheeze
| Study | N | Study population | Design | Age | Intervention | Duration | Findings | |
|---|---|---|---|---|---|---|---|---|
| ED all pre-school age range | Csonka 2003 | 230 | ED | Parallel - 2 arm | 6-35 mo | Prednisolone | 3 days | Significantly fewer prednisolone patients needed additional asthma medication. Significantly shorter hospital stay. No reduction in hospitalisation. |
| Exclusion = 2 or more previous episodes of wheezing | 2 mg/kg/day | |||||||
| Panickar 2009 | 687 | Hospitalised children | Parallel - 2 arm | 10 mo - 6 y | Prednisolone | 5 days | No reduction in time to discharge. | |
| 20 mg/day | ||||||||
| (10 mg for <2 years) | ||||||||
| ED< 2 years | Daugbjerg 1993 | 123 | Hospitalised children | Parallel - 4 arm | 1.5-18 mo | 1. Prednisolone & Terbutaline 2. Budesonide & Terbutaline 3. Terbutaline alone | 3 days | Children from each of the prednisolone & bud groups discharged significantly earlier |
| 4. Placebo alone | ||||||||
| Prednisolone | ||||||||
| D1 4-6 mg/kg | ||||||||
| D2&3 2 mg/kg | ||||||||
| Fox 1996 | 59 | Hospitalised children | Parallel - 3 arm | 3-14 mo | Salbutamol plus prednisolone (2 mg/kg) or placebo or double placebo | 5 days | No difference in treatment failures between prednisolone & placebo | |
| Inclusion = 1 or more previous episodes wheezing | ||||||||
| Parent initiated | Grant 1995 | 86 | ED / primary care | Crossover - 2 arm | 2-14 y | Prednisolone | 1 dose | No reduction in outpatient visits or hospitalisation |
| Inclusion = 2 or more visits with wheezing in last year | 2 mg/kg | |||||||
| Oommen 2003 | 233 | Previously hospitalised children | Parallel - 2 arm | 1-5 y | Prednisolone | 5 days | No difference in symptom score or hospital admissions | |
| 20 mg/day |